Literature DB >> 22387162

The dynamics of drug resistance: a mathematical perspective.

Orit Lavi1, Michael M Gottesman, Doron Levy.   

Abstract

Resistance to chemotherapy is a key impediment to successful cancer treatment that has been intensively studied for the last three decades. Several central mechanisms have been identified as contributing to the resistance. In the case of multidrug resistance (MDR), the cell becomes resistant to a variety of structurally and mechanistically unrelated drugs in addition to the drug initially administered. Mathematical models of drug resistance have dealt with many of the known aspects of this field, such as pharmacologic sanctuary and location/diffusion resistance, intrinsic resistance, induced resistance and acquired resistance. In addition, there are mathematical models that take into account the kinetic/phase resistance, and models that investigate intracellular mechanisms based on specific biological functions (such as ABC transporters, apoptosis and repair mechanisms). This review covers aspects of MDR that have been mathematically studied, and explains how, from a methodological perspective, mathematics can be used to study drug resistance. We discuss quantitative approaches of mathematical analysis, and demonstrate how mathematics can be used in combination with other experimental and clinical tools. We emphasize the potential benefits of integrating analytical and mathematical methods into future clinical and experimental studies of drug resistance. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387162      PMCID: PMC3348255          DOI: 10.1016/j.drup.2012.01.003

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  65 in total

1.  Mathematics and oncology: a match for life?

Authors:  Martine J Piccart-Gebhart
Journal:  J Clin Oncol       Date:  2003-02-13       Impact factor: 44.544

2.  A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance.

Authors:  S Michelson; D Slate
Journal:  Bull Math Biol       Date:  1992-11       Impact factor: 1.758

3.  Some optimal control problems in cancer chemotherapy with a toxicity limit.

Authors:  J M Murray
Journal:  Math Biosci       Date:  1990-06       Impact factor: 2.144

4.  Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.

Authors:  Torben S Mikkelsen; Alex Sparreboom; Cheng Cheng; Yinmei Zhou; James M Boyett; Susana C Raimondi; John C Panetta; W Paul Bowman; John T Sandlund; Ching-Hon Pui; Mary V Relling; William E Evans
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

5.  Optimal control analysis in the chemotherapy of IgG multiple myeloma.

Authors:  G W Swan; T L Vincent
Journal:  Bull Math Biol       Date:  1977       Impact factor: 1.758

6.  Rationale for the use of alternating non-cross-resistant chemotherapy.

Authors:  J H Goldie; A J Coldman; G A Gudauskas
Journal:  Cancer Treat Rep       Date:  1982-03

7.  A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.

Authors:  John Carl Panetta; Yuri Yanishevski; Ching-Hon Pui; John T Sandlund; Jeffrey Rubnitz; Gaston K Rivera; Raul Ribeiro; William E Evans; Mary V Relling
Journal:  Cancer Chemother Pharmacol       Date:  2002-09-24       Impact factor: 3.333

8.  Does tumor growth follow a "universal law"?

Authors:  Caterina Guiot; Piero Giorgio Degiorgis; Pier Paolo Delsanto; Pietro Gabriele; Thomas S Deisboeck
Journal:  J Theor Biol       Date:  2003-11-21       Impact factor: 2.691

9.  Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies.

Authors:  Raja Venkatasubramanian; Michael A Henson; Neil S Forbes
Journal:  J Theor Biol       Date:  2008-02-21       Impact factor: 2.691

10.  A mathematical model for the inhibition of the multidrug resistance-associated P-glycoprotein pump.

Authors:  S Michelson; D Slate
Journal:  Bull Math Biol       Date:  1994-03       Impact factor: 1.758

View more
  29 in total

Review 1.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

2.  Microenvironmental Niches and Sanctuaries: A Route to Acquired Resistance.

Authors:  Judith Pérez-Velázquez; Jana L Gevertz; Aleksandra Karolak; Katarzyna A Rejniak
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  Modeling intrinsic heterogeneity and growth of cancer cells.

Authors:  James M Greene; Doron Levy; King Leung Fung; Paloma S Souza; Michael M Gottesman; Orit Lavi
Journal:  J Theor Biol       Date:  2014-11-29       Impact factor: 2.691

4.  Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases.

Authors:  Ami B Shah; Katarzyna A Rejniak; Jana L Gevertz
Journal:  Math Biosci Eng       Date:  2016-12-01       Impact factor: 2.080

Review 5.  Development of nanomaterials for bone-targeted drug delivery.

Authors:  Hao Cheng; Aditya Chawla; Yafeng Yang; Yuxiao Li; Jin Zhang; Hae Lin Jang; Ali Khademhosseini
Journal:  Drug Discov Today       Date:  2017-05-06       Impact factor: 7.851

6.  Redundancy: a critical obstacle to improving cancer therapy.

Authors:  Orit Lavi
Journal:  Cancer Res       Date:  2015-01-09       Impact factor: 12.701

7.  The impact of cell density and mutations in a model of multidrug resistance in solid tumors.

Authors:  James Greene; Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Bull Math Biol       Date:  2014-02-20       Impact factor: 1.758

8.  Simplifying the complexity of resistance heterogeneity in metastasis.

Authors:  Orit Lavi; James M Greene; Doron Levy; Michael M Gottesman
Journal:  Trends Mol Med       Date:  2014-01-31       Impact factor: 11.951

9.  Understanding Drug Resistance in Breast Cancer with Mathematical Oncology.

Authors:  Terisse Brocato; Prashant Dogra; Eugene J Koay; Armin Day; Yao-Li Chuang; Zhihui Wang; Vittorio Cristini
Journal:  Curr Breast Cancer Rep       Date:  2014-06-01

10.  The role of cell density and intratumoral heterogeneity in multidrug resistance.

Authors:  Orit Lavi; James M Greene; Doron Levy; Michael M Gottesman
Journal:  Cancer Res       Date:  2013-10-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.